封面
市场调查报告书
商品编码
1390612

免疫组织化学市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Immunohistochemistry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球免疫组化市场规模达24亿美元。展望未来, IMARC Group预计到2028年市场规模将达到38亿美元,2022-2028年复合年增长率(CAGR)为7.96%。

免疫组织化学 (IHC) 是一种使用抗体检查组织样本中特定抗原的实验室方法。这些抗体通常与酵素或萤光染料结合,这有助于研究人员在显微镜下观察抗原。 IHC 广泛用于诊断癌症等慢性疾病,并有助于区分其类型。与识别有限数量的蛋白质、酵素和组织结构的传统酵素染色技术相比,IHC 涉及特异性抗原抗体反应。因此,它作为医学研究实验室和临床诊断中的关键技术而受到关注,以可视化细胞内特定细胞成分的分布和定位。

免疫组织化学市场趋势:

冠状病毒病(COVID-19)的突然发作导致了全球医疗保健危机。这加大了对 IHC 的需求,以实现快速有效的药物开发和感染诊断。除此之外,患有癌症、肿瘤、肌肉疾病和神经退化性疾病的人数显着增长是推动市场的另一个关键因素。此外,IHC 可以表征各种生物过程和病理学,包括伤口癒合、免疫反应、组织排斥和生物材料相互作用。因此,确定特定基因产物在基本生物过程中的功能并确认组织中的感染因子越来越受到关注。此外,最近还推出了几种新型萤光染料、出色的色彩对比、高解析度和同时多色成像。预计这些创新将使免疫萤光显微镜成为未来几年研究细胞层面病理生物学过程的便利工具。

本报告回答的关键问题:

  • 迄今为止,全球免疫组化市场表现如何,未来几年将如何表现?
  • COVID-19 对全球免疫组织化学市场有何影响?
  • 主要区域市场有哪些?
  • 基于产品的市场区隔是什么?
  • 基于应用程式的市场区隔是什么?
  • 根据最终用途分類的市场是怎样的?
  • 产业价值链的各个阶段是什么?
  • 该行业的关键驱动因素和挑战是什么?
  • 全球免疫组化市场的结构如何?谁是主要参与者?
  • 产业竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球免疫组织化学市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:按产品分類的市场区隔

  • 抗体
    • 市场走向
    • 关键环节
      • 一抗
      • 二抗
    • 市场预测
  • 装置
    • 市场走向
    • 关键环节
      • 玻片染色系统
      • 组织微阵列
      • 组织处理系统
      • 玻片扫描仪
      • 其他的
    • 市场预测
  • 试剂
    • 市场走向
    • 关键环节
      • 组织学染色
      • 封闭血清和试剂
      • 显色底物
      • 固定试剂
      • 稳定剂
      • 有机溶剂
      • 蛋白水解酶
      • 稀释剂
    • 市场预测
  • 套件
    • 市场走向
    • 市场预测

第 7 章:按应用分類的市场区隔

  • 诊断
    • 市场走向
    • 关键环节
      • 癌症
      • 传染性疾病
      • 心血管疾病
      • 自体免疫疾病
      • 糖尿病
      • 肾臟病
    • 市场预测
  • 药物检测
    • 市场走向
    • 市场预测

第 8 章:依最终用途分類的市场区隔

  • 医院和诊断实验室
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章:按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章:价格分析

第14章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4404

Abstract

The global immunohistochemistry market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.96% during 2022-2028.

Immunohistochemistry (IHC) is a laboratory method for checking specific antigens in a tissue sample using antibodies. The antibodies generally bind to an enzyme or a fluorescent dye, which helps researchers see an antigen under a microscope. IHC is widely used to diagnose chronic diseases like cancer and aids in distinguishing their types. As compared to conventional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures, IHC involves specific antigen-antibody reactions. As a result, it is gaining traction as a crucial technique in medical research laboratories and clinical diagnostics to visualize the distribution and localization of specific cellular components within cells.

Immunohistochemistry Market Trends:

The sudden onset of coronavirus disease (COVID-19) has led to a global healthcare crisis. This is escalating the need for IHC for quick and effective drug development and diagnosis of the infection. Apart from this, significant growth in the number of individuals who have cancer, tumors, muscle diseases, and neurodegenerative disorders acts as another key factor driving the market. Moreover, IHC can characterize various biological processes and pathologies, including wound-healing, immune response, and tissue rejection and biomaterial interactions. As a result, it is gaining traction to determine the function of specific gene products in fundamental biological processes and confirm infectious agents in tissues. Moreover, several novel fluorescent dyes, excellent color contrast, high resolution, and simultaneous multicolor imaging have been introduced recently. These innovations are anticipated to make immunofluorescence microscopy a convenient tool for studying pathobiological processes at the cellular level in the forthcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohistochemistry market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, end use.

Breakup by Product:

Antibodies

Primary Antibodies

Secondary Antibodies

Equipment

Slide Staining Systems

Tissue Microarrays

Tissue Processing Systems

Slide Scanners

Others

Reagents

Histological Stains

Blocking sera and Reagents

Chromogenic Substrates

Fixation Reagents

Stabilizers

Organic Solvents

Proteolytic Enzymes

Diluents

Kits

Breakup by Application:

Diagnostics

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Diabetes Mellitus

Nephrological Diseases

Drug Testing

Breakup by End Use:

Hospitals and Diagnostic Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunohistochemistry market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohistochemistry market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players